Ylisaukko-Oja T, Puttonen M, Jokelainen J, Koivusalo M, et al. Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice. Scand J Gastroenterol 2022;57:415-423.
PMID: 34927504